Danielle Borg

Dr Borg is an early-career scientist who has authored 38 peer-reiviewed publications in the field of Women's Health, Diabetes, Biomaterial Transplantation, Islet Transplantation, Stem Cell Biology, RAGE/AGE Biology, and Scientific Engagement. Relative to opportunity with program management roles and carers leave since 2018, her research achievements have been exceptional with a FWCI of 1.91, 22 publications with 158 citations, and 4 publications listed in the top 10% most cited worldwide.

Dr Borg has completed research positions in Germany and Australia and has contributed to organising committees for scientific outreach programs, conferences and global communities. She has been supported by a number of mentors throughout her career and is an avid believer in providing mentorship to support the next generation of researchers. She enjoys supporting indviduals find their passion for their career path.

She currently oversee Queensland’s most comprehensive longitudinal birth cohort, tracking families from preconception to age 5. This research has the potential to provide critical insight into developmental, environmental, and biological factors influencing maternal and child health, identifying key intervention periods to prevent chronic diseases and improve population health. With a biobank of over 60,000 samples, the Queensland Family Cohort will have the ability to inform policymakers on effective evidence-based health strategies for maternal and child health. Our whole family approach has highlighted the importance of partners in healthy pregnancies and mothers’ mental health (https://tinyurl.com/3naf67v8). This work could contribute to national and global knowledge on human developmental origins of disease with practical implications for improving women health and well-being. Dr Borg concurrently holds a Principal Research Fellow position in the Women-Newborn-Children’s Service (WNCS) at Gold Coast HHS (GCHHS), where she develops and co-designs the research agenda and build workforce capacity across seven research groups. These groups cover maternal health, the first 2000 days of life, and child and adolescent community health. By guiding clinical researchers, our evaluations of novel models-of-care have the potential to improve health outcomes for women and children.